We brought together – and are qualitatively advancing – technologies to make scalable peptide drug design a reality.
- Our novel, proprietary AI algorithms drive intelligent navigation of otherwise unexplored and inaccessible peptide chemical space to find new peptides with a desired set of properties.
- Our purpose-built supercomputer and cutting-edge AI engine execute the algorithms far faster than otherwise possible, maximizing the accuracy of our models and, thereby, the quality of our hits.
- Innovations we’re bringing to the lab are enabling rapid, cost-effective, scalable peptide synthesis coupled with rich data collection, to allow continual improvement over time.
This confluence is making possible a transformation in the very way that we do drug discovery, and enabling a move to AI-enabled design. Multiparameter optimization allows us to engineer a spectrum of properties into designed peptides, which radically focuses our search and accelerates our time to discovery.